Transce3nd’s Acadia Healthcare ACHC Stock Holding History

Transce3nd’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40	Closed	-$908	–	167
2025 Q2	$908	Hold	40	–	–	﹤0.01%	1002
2025 Q1	$1.21K	Hold	40	–	–	﹤0.01%	933
2024 Q4	$1.59K	Buy	+40	New	+$1.8K	﹤0.01%	1141

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Transce3nd's ACHC Position: Q3 2025 in Review

Transce3nd sold out of Acadia Healthcare (ACHC) in Q3 2025, closing a stake of 40 shares — an estimated $908 sold.

Transce3nd first reported a position in ACHC in Q4 2024 and held it in 3 quarters. The position peaked at $1.59K in Q4 2024. 270 funds tracked by Wall St. Rank hold ACHC as of Q3 2025.

Transce3nd reported no remaining Acadia Healthcare position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 40 Acadia Healthcare shares in Q3 2025, an estimated $908.
Transce3nd first reported a position in Acadia Healthcare in Q4 2024 and held it in 3 quarters.
Transce3nd's Acadia Healthcare position peaked at $1.59K in Q4 2024.
270 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.